Public Acceptance and Willingness-to-Pay for a Future Dengue Vaccine: A Community-Based Survey in Bandung, Indonesia

PLoS Neglected Tropical Diseases

Volumn 7, Issue 9, 2013, Pages

  Hadisoemarto, Panji Fortuna ^a,b   Castro, Marcia C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b PADJADJARAN UNIVERSITY   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BEHAVIOR CHANGE; COMMUNITY; DENGUE; FEMALE; FEVER; HEALTH SURVEY; HUMAN; MALE; PETECHIA; PROPHYLAXIS; PUBLIC OPINION; QUESTIONNAIRE; SCORING SYSTEM; SOCIAL PARTICIPATION; SOCIOECONOMICS; VACCINATION; VECTOR CONTROL;

DENGUE; DENGUE VACCINES; FAMILY CHARACTERISTICS; FEMALE; HUMANS; INDONESIA; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES;

EID: 84884694579     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002427     Document Type: Article

References (43)

1. World Health Organization (2009) Dengue and dengue hemorrhagic fever. Available: http://www.who.int/mediacentre/factsheets/fs117/en/index.html. Accessed 15 November 2010.
2. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature 496: 504-507.
3. Ministry of Health Republic of Indonesia (2011) Indonesia Health Profile 2010 (in Bahasa Indonesia). Jakarta: Ministry of Health Republic of Indonesia.
4. Setiati TE, Wagenaar JF, Kruif MDd, Mairuhu AT, Gorp WCv, et al. (2006) Changing epidemiology of dengue hemorrhagic fever in Indonesia. Dengue Bulletin 30.
5. Kusriastuti R, Sutomo S, (2005) Evolution of dengue prevention and control programme in Indonesia. Dengue Bulletin 29: 1-7.
6. Gubler DJ, (1998) Dengue and dengue hemorrhagic fever. Clinical Microbiology Reviews 11: 480-496.
7. Webster DP, Farrar J, Rowland-Jones S, (2009) Progress towards a dengue vaccine. Lancet Infectious Disease 9: 678-687.
8. Lang J, (2009) Recent progress on sanofi pasteur's dengue vaccine candidate. Journal of Clinical Virology 46: 20-24.
9. DeRoeck D, Deen J, Clemens JD, (2003) Policymakers' view on dengue fever/dengue hemorrhagic fever and the need for dengue vaccines in four southeast Asian countries. Vaccine 22: 121-129.
10. World Health Organization (2011) Expanded Program in Immunization- Country Situation. Available: http://www.ino.searo.who.int/EN/Section4/Section12_80.htm. Accessed 8 July 2012.
11. Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S, (2011) Addressing the vaccine confidence gap. Lancet 378: 526-535.
12. Godlee F, Smith J, Marcovitch H, (2011) Wakefield's article linking MMR vaccine and autism was fraudulent. BMJ 342: c7452.
13. Hapsari AD (2010) MUI dismisses experts' claim on vaccine, defends fatwa. The Jakarta Post 9 August 2010. Online. Available: http://www.thejakartapost.com/news/2010/08/09/mui-dismisses-experts%E2%80%99-claim-vaccine-defends-fatwa.html. Accessed 8 July 2012.
14. Jaspers L, Budiningsih S, Wolterbeek R, Henderson FC, Peters AAW, (2011) Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: A cross-sectional study. Vaccine 29: 7785-7793.
15. Agtini MD, Ochiai RL, Soeharno R, Lee HJ, Sundoro J, et al. (2006) Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform. Public Health 120: 1081-1087.
16. Mahoney RT, Ramachandran S, Xu Z-Y, (2000) The introduction of new vaccines into developing countries II. Vaccine financing. Vaccine 18: 2625-2635.
17. World Health Organization (2003) Regional vaccine policy for South-East Asia region. New Delhi: WHO Regional Office for South-East Asia.
18. World Health Organization (2005) Vaccine introduction guidelines.Available: http://www.who.int/nuvi/Vaccine_intro_resources/en/. Accessed 15 November 2010.
19. Palanca-Tan R, (2008) The demand for a dengue vaccine: a contingent valuation survey in Metro-Manila. Vaccine 26: 914-923.
20. Newman PA, Lee S-J, Duan N, Rudy E, Nakazono TK, et al. (2009) Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES). Health Services Research 44: 2167-2179.
21. Pialoux G, Gauzere B-A, Jaureguiberry S, Strobel M, (2007) Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 7: 319-327.
22. Laras K, Sukri N, Larasati R, Bangs M, Kosim R, et al. (2005) Tracking the re-emergence of epidemic chikungunya virus in Indonesia. Transactions of the Royal Society of Tropical Medicine and Hygiene 99: 128-141.
23. Kosasih H, Widjaja S, Hadisoemarto PF, Nurhayati, Tan R, et al. (2005) Findings of Chikungunya fever cases during a prospective study of dengue in Bandung, Indonesia. 11th National Conference of Infectious Diseases and Tropical Medicine. Solo, Indonesia.
24. Bandung Municipality Health Office (2011) Bandung Health Profile 2010 (in Bahasa Indonesia). Bandung: Bandung Municipality Health Office.
25. Porter KR, Beckett CG, Kosasih H, Tan RI, Alisjahbana B, et al. (2005) Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia The American. Journal of Tropical Medicine and Hygiene 72: 60-66.
26. Filmer D, Pritchett L, (1999) The effect of household wealth on educational attainment: Evidence from 35 Countries. Population and Development Review 25: 85-120.
27. Cortina JM, (1993) What is coefficient Alpha? An examination of theory and applications. Journal of Applied Psychology 78: 98-104.
28. Masters JR, (1974) The relationship between number of response categories and reliability of Likert-type questionnaires. Journal of Educational Measurement 11: 49-53.
29. Ananth CV, Kleinbaum DG, (1997) Regression models for ordinal responses: A review of methods and applications. International Journal of Epidemiology 26: 1323-1333.
30. Cameron TA, (1988) A new paradigm for valuing non-market goods using referendum data: Maximum Likelihood Estimation by censored logistic regression. Journal of Environmental Economics and Management 15: 355-379.
31. Simpson SN, Hanna BG, (2010) Willingness to pay for a clear night sky: Use of the contingent valuation method. Applied Economics Letters 17: 1095-1103.
32. Dempsey AF, Zimet GD, Davis RL, Koutsky L, (2006) Factors that are associated with parental acceptance of Human Papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics 117: 1486-1493.
33. Sita W (2012) Dengue fever spikes in Tangerang regency. The Jakarta Post 18 April 2012. Online. available: http://www.thejakartapost.com/news/2012/04/18/dengue-fever-spikes-tangerang-regency.html. Accessed 10 July 2012.
34. Mahoney RT, Francis DP, Frazatti-Gallina NM, Precioso AR, Raw I, et al. (2012) Cost of production of live attenuated dengue vaccines: A case study of the Instituto Butantan, Sao Paulo, Brazil. Vaccine 30: 4892-4896.
35. Frost LJ, Reich MR (2008) Hepatitis B vaccine: Access to vaccine. Access: How do good health technologies get to poor people in poor countries? Cambridge, Massachusetts: Harvard Center for Population and Development Studies.
36. Dahlstrom LA, Tran TN, Lundholm C, Young C, Sundstrom K, et al. (2009) Attitudes to HPV vaccination among parents of children aged 12-25 years- A population-based survey in Sweden. International Journal of Cancer 126: 500-507.
37. Focks DA, Chadee DD, (1997) Pupal survey: An epidemiologically significant surveillance method for Aedes aegypti: An example using data from Trinidad. The American Journal of Tropical Medicine and Hygiene 56: 159-167.
38. Maciel-de-Freitas R, Lourenço-de-Oliveira R, (2011) Does targeting key-containers effectively reduce Aedes aegypti population density? Tropical Medicine & International Health 16: 965-973.
39. Pilger D, Lenhart A, Manrique-Saide P, Siqueira JB, da Rocha WT, et al. (2011) Is routine dengue vector surveillance in central Brazil able to accurately monitor the Aedes aegypti population? Results from a pupal productivity survey. Tropical Medicine & International Health 16: 1143-1150.
40. Focks DA, Bangs MJ, Church C, Juffrie M, Nalim S, (2007) Transmission threshold and pupal/demographic surveys in Yogyakarta, Indonesia for developing a dengue control strategy based on targerting epidemiologically significant types of water-holding containers. Dengue Bulletin 31: 83-103.
41. Wong J, Morrison AC, Stoddard ST, Astete H, Chu YY, et al. (2012) Linking oviposition site choice to offspring fitness in Aedes aegypti: Consequences for targeted larval control of dengue vectors. PLoS Negl Trop Dis 6: e1632.
42. Diamond PA, Hausman JA, (1994) Contingent valuation: Is some number better than no number? The Journal of Economic Perspectives 8: 45-64.
43. Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, et al. (2012) Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. The Lancet 380: 1559-1567.